1-9 of 9
D Huhn
Close
Sort by
Journal Articles

A Phase 1 Study Evaluating BI 765063, a First in Class Selective Myeloid Sirpa Inhibitor, As Stand-Alone and in Combination with BI 754091, a Programmed Death-1 (PD-1) Inhibitor, in Patients with Advanced Solid Tumours

Jean-Pierre Delord, MD, Nuria Kotecki, MD, Aurelien Marabelle, MD PhD, Armelle Vinceneux, MD, Iphigenie Korakis, MD, Christiane Jungels, MD, Stéphane Champiat, MD, Richard D. Huhn, MD, Nicolas Poirier, PhD, Dominique Costantini, MD, Bérangère Vasseur, MD, Philippe A. Cassier, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1040.
https://doi.org/10.1182/blood-2019-124876
Published: 2019
Journal Articles

High-dose cyclophosphamide with autologous lymphocyte–depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia

Clinical Trials & Observations
Richard D. Huhn, Patrick F. Fogarty, Ryotaro Nakamura, Elizabeth J. Read, Susan F. Leitman, Margaret E. Rick, Janice Kimball, Adeira Greene, Kristin Hansmann, Alois Gratwohl, Neal Young, A. John Barrett, Cynthia E. Dunbar
Journal: Blood
Blood (2003) 101 (1): 71–77.
https://doi.org/10.1182/blood-2001-12-0171
Published: 2003
Journal Articles

Plasmablastic Lymphomas of the Oral Cavity: A New Entity Associated With the Human Immunodeficiency Virus Infection

H.J. Delecluse, I. Anagnostopoulos, F. Dallenbach, M. Hummel, T. Marafioti, U. Schneider, D. Huhn, A. Schmidt-Westhausen, P.A. Reichart, U. Gross, H. Stein
Journal: Blood
Blood (1997) 89 (4): 1413–1420.
https://doi.org/10.1182/blood.V89.4.1413
Published: 1997
Journal Articles

Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis

A Neubauer, A Fiebeler, DK Graham, JP O'Bryan, CA Schmidt, P Barckow, S Serke, W Siegert, HR Snodgrass, D Huhn
Journal: Blood
Blood (1994) 84 (6): 1931–1941.
https://doi.org/10.1182/blood.V84.6.1931.1931
Published: 1994
Journal Articles

Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas [see comments]

HH Gerhartz, M Engelhard, P Meusers, G Brittinger, W Wilmanns, G Schlimok, P Mueller, D Huhn, R Musch, W Siegert
Journal: Blood
Blood (1993) 82 (8): 2329–2339.
https://doi.org/10.1182/blood.V82.8.2329.2329
Published: 1993
Journal Articles

Quantitation of CD34+ cells [letter; comment]

S Serke, D Huhn
Journal: Blood
Blood (1992) 80 (6): 1628–1630.
https://doi.org/10.1182/blood.V80.6.1628.1628
Published: 1992
Journal Articles

Chronic leukemia with a hybrid surface phenotype (T lymphocytic/myelomonocytic): leukemic cells displaying natural killer activity and antibody-dependent cellular cytotoxicity

G Schlimok, E Thiel, EP Rieber, D Huhn, H Feucht, J Lohmeyer, G Riethmuller
Journal: Blood
Blood (1982) 59 (6): 1157–1162.
https://doi.org/10.1182/blood.V59.6.1157.1157
Published: 1982
Journal Articles

Multimarker classification of acute lymphoblastic leukemia: evidence for further T subgroups and evaluation of their clinical significance

E Thiel, H Rodt, D Huhn, B Netzel, H Grosse-Wilde, K Ganeshaguru, S Thierfelder
Journal: Blood
Blood (1980) 56 (5): 759–772.
https://doi.org/10.1182/blood.V56.5.759.759
Published: 1980
Journal Articles

Decrease and altered distribution of human T antigen on chronic lymphatic leukemia cells of T type, suggesting a clonal origin

E Thiel, H Rodt, D Huhn, S Thierfelder
Journal: Blood
Blood (1976) 47 (5): 723–736.
https://doi.org/10.1182/blood.V47.5.723.723
Published: 1976